IVD Medical Holding Limited (HKG:1931)

Market Cap	14.12B
Revenue (ttm)	3.37B
Net Income (ttm)	277.13M
Shares Out	1.62B
EPS (ttm)	0.19
PE Ratio	47.05
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,912,000
Average Volume	4,608,663
Open	8.56
Previous Close	8.64
Day's Range	7.90 - 9.01
52-Week Range	0.62 - 12.86
Beta	-0.35
RSI	71.84
Earnings Date	Aug 18, 2025

About IVD Medical Holding

IVD Medical Holding Limited, an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, After-sales Services, and Self-branded Products Business. It offers IVD analysers, reagents, and other consumables for various IVD testing categories, including hematology and body fluid, immunoassay, clinical chemistry, immunology, microbiology, and point-of-care testing. The company also provides haemostasis products; solution servi...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1993
• Employees: 863
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1931

Financial Performance

In 2024, IVD Medical Holding's revenue was 3.16 billion, an increase of 2.40% compared to the previous year's 3.09 billion. Earnings were 260.42 million, an increase of 9.35%.

Financial numbers in CNY